Source:http://linkedlifedata.com/resource/pubmed/id/12209606
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2002-9-4
|
pubmed:abstractText |
E-cadherin plays a major role in intercellular adhesion, cell polarity and tissue architecture. We determined the relative risk of PCa associated with a previously reported C/A SNP at -160 bp relative to the transcription-start site of the E-cadherin gene promoter. Eighty-two PCa patients and 188 controls were genotyped. Genotype and allele frequencies differed significantly among cases and controls. A-allele carriers had a higher relative risk of PCa (OR = 3.6, 95% CI 2.0-6.4) compared to C-only carriers. AC and AA genotypes had an increased risk of PCa (OR = 3.8, 95% CI 2.1-6.8 and OR = 1.7, 95% CI 0.4-6.6, respectively) compared to CC genotypes.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0020-7136
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2002 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
100
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
683-5
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12209606-Aged,
pubmed-meshheading:12209606-Alleles,
pubmed-meshheading:12209606-Cadherins,
pubmed-meshheading:12209606-Case-Control Studies,
pubmed-meshheading:12209606-Genotype,
pubmed-meshheading:12209606-Humans,
pubmed-meshheading:12209606-Male,
pubmed-meshheading:12209606-Middle Aged,
pubmed-meshheading:12209606-Polymorphism, Single Nucleotide,
pubmed-meshheading:12209606-Promoter Regions, Genetic,
pubmed-meshheading:12209606-Prostatic Neoplasms,
pubmed-meshheading:12209606-Risk
|
pubmed:year |
2002
|
pubmed:articleTitle |
Single-nucleotide polymorphism in the E-cadherin gene promoter modifies the risk of prostate cancer.
|
pubmed:affiliation |
Department of Urology (252 EPIB), University Medical Centre Nijmegen, NL-6500 HB Nijmegen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|